SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-221220
Filing Date
2019-08-14
Accepted
2019-08-14 16:18:10
Documents
15
Period of Report
2019-08-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d778241d8k.htm   iXBRL 8-K 33445
2 EX-1.1 d778241dex11.htm EX-1.1 147667
3 EX-5.1 d778241dex51.htm EX-5.1 8270
7 GRAPHIC g778241g05x75.jpg GRAPHIC 10248
  Complete submission text file 0001193125-19-221220.txt   363456

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptla-20190813.xsd EX-101.SCH 3065
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20190813_lab.xml EX-101.LAB 17372
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20190813_pre.xml EX-101.PRE 10949
8 EXTRACTED XBRL INSTANCE DOCUMENT d778241d8k_htm.xml XML 3109
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35935 | Film No.: 191026653
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences